(Q36791143)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1743314%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

review article

1 reference

title

Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1743314%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

0 references

R. Orvieto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1743314

14 November 2022

A. Achiron

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1743314

14 November 2022

Z. Ben-Rafael

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1743314

14 November 2022

R. Achiron

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1743314

14 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1743314%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.elsevier.com/content/article/PII:S0015028216547086?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54708-6

https://api.elsevier.com/content/article/PII:S0015028216547086?httpAccept=text/plain

14 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54708-6

14 November 2022

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1743314%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1743314%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1743314%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

1013-1020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1743314%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

cites work

Recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Recurrent miscarriage. II: Clinical associations, causes, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Antibodies to phospholipids and nuclear antigens in patients with repeated abortions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

"Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Antiphospholipid antibodies in early repeated abortions: a case-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Lupus anticoagulant and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Intrauterine death and circulating anticoagulant ("antithromboplastin")

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Lupus anticoagulant in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Spontaneous recurrent fetal wastage and autoimmune abnormalities: a study of fourteen cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Lupus anticoagulant in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Vascular disease, thrombosis, and recurrent abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Reduced prostacyclin production in pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

THROMBOTIC TENDENCY IN SYSTEMIC LUPUS ERYTHEMATOSUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

"Lupus" anticoagulant and prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Pathophysiology of antiphospholipid antibodies: absence of prostaglandin-mediated effects on cultured endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Fetal loss treatment in patients with antiphospholipid antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Recurrent adverse pregnancy outcome and antiphospholipid antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Low-dose aspirin in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Treatment of habitual abortions associated with autoimmune abnormalities. A report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Obstetric complications associated with the lupus anticoagulant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Recurrent abortion with lupus anticoagulant, and pre-eclampsia: a common final pathway for two different diseases? Case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

7 January 2021

Anticardiolipin antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Intravenous gamma-globulin, antiphospholipid antibodies, and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Clinical uses of intravenous immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Immunoglobulin A concentrations in commercial immune globulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: inadequacy of current dosage practices and approaches to the problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Intravenous immune globulin therapy in hypogammaglobulinemia. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

SLE anticoagulant: transient inhibition by high dose immunoglobulin infusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Prevention of recurrent spontaneous abortion by intravenous immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

The participation of B cells and antibodies in the selection and maintenance of T cell repertoires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Current concepts: immunology. Idiotypes and idiotypic networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Idiotypic networks and other preconceived ideas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Australia Antigen: Distribution during Cohn Ethanol Fractionation of Human Plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

Anti-phospholipid antibody and pregnancy wastage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

inferred from DOI database lookup

7 January 2021

based on heuristic

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954708-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Hazards of lupus pregnancy

9

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54708-6

Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus

14 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54708-6

Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage

14 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54708-6

Pregnancy and lupus: prognostic indicators and response to treatment

14 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54708-6

Human immunoglobulin therapy for preeclampsia associated with lupus anticoagulant and anticardiolipin antibody

14 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54708-6

Idiotypes and autoimmunity

14 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54708-6

14 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1743314%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference